BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19181031)

  • 21. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
    Dutil M
    Skin Therapy Lett; 2010; 15(10):5-7. PubMed ID: 21076800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact and importance of resistance.
    Tanghetti E
    Cutis; 2007 Jul; 80(1 Suppl):5-9. PubMed ID: 17824580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria.
    Eady EA; Bojar RA; Jones CE; Cove JH; Holland KT; Cunliffe WJ
    Br J Dermatol; 1996 Jan; 134(1):107-13. PubMed ID: 8745894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of benzoyl peroxide in the new treatment paradigm for acne.
    Kircik LH
    J Drugs Dermatol; 2013 Jun; 12(6):s73-6. PubMed ID: 23839205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical dose justification: benzoyl peroxide concentrations.
    Brandstetter AJ; Maibach HI
    J Dermatolog Treat; 2013 Aug; 24(4):275-7. PubMed ID: 22103743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.
    Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC
    Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance?
    Kinney MA; Yentzer BA; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2010 May; 9(5):519-24. PubMed ID: 20480795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne.
    Bikowski J; Del Rosso JQ
    J Drugs Dermatol; 2008 Jun; 7(6):590-5. PubMed ID: 18561594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization.
    Tanghetti EA; Popp KF
    Dermatol Clin; 2009 Jan; 27(1):17-24. PubMed ID: 18984364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy].
    Fluhr JW; Degitz K
    J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S24-30. PubMed ID: 20482689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro antimicrobial activity of benzoyl peroxide against Propionibacterium acnes assessed by a novel susceptibility testing method.
    Okamoto K; Ikeda F; Kanayama S; Nakajima A; Matsumoto T; Ishii R; Umehara M; Gotoh N; Hayashi N; Iyoda T; Matsuzaki K; Matsumoto S; Kawashima M
    J Infect Chemother; 2016 Jun; 22(6):426-9. PubMed ID: 26806150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D
    MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.
    Abdel Fattah NS; Darwish YW
    J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1546-51. PubMed ID: 23279041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
    Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
    Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
    Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne.
    Kircik L
    Cutis; 2007 Jul; 80(1 Suppl):10-4. PubMed ID: 17824581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzoyl peroxide and clindamycin topical skin preparation decreases Propionibacterium acnes colonization in shoulder arthroscopy.
    Dizay HH; Lau DG; Nottage WM
    J Shoulder Elbow Surg; 2017 Jul; 26(7):1190-1195. PubMed ID: 28479255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.